MARSH & MCLENNAN COMPANIES, INC. (MRSH) Stock
MRSH has an Alpha Score of 55 out of 100 (weak), computed on Oct 29, 2026 from 3 of 4 sub-scores. 2 members of Congress disclosed 7 trades in MRSH since 2026: 0 purchases and 7 sales, most recently Kevin Hern (sale, Sep 23, 2026). 5 of the hedge funds AlphaScala tracks reported MRSH in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Marshall Wace's at $173.90M. Company insiders reported 0 open-market buys and 5 sales on SEC Form 4 in the 90 days to Nov 3, 2026. Its trailing P/E ratio is 23.9 and its net margin 14.2% (key statistics as of Nov 3, 2026).
What is MRSH's Alpha Score?
How it works →Alpha Score of 55 reflects moderate overall profile with strong momentum, weak value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 29, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded MARSH & MCLENNAN COMPANIES, INC. (MRSH)?
Most recent: Kevin Hern (sale, Sep 23, 2026); records start Mar 27, 2026.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Kevin Hern R-OK · House | 2026-09-23 | sale | $50k – $100k |
| Kevin Hern R-OK · House | 2026-09-17 | partial sale | $50k – $100k |
| Kevin Hern R-OK · House | 2026-09-14 | partial sale | $1k – $15k |
| Kevin Hern R-OK · House | 2026-09-09 | partial sale | $100k – $250k |
| Kevin Hern R-OK · House | 2026-09-02 | partial sale | $1k – $15k |
| Kevin Hern R-OK · House | 2026-08-24 | sale | $1k – $15k |
| Alan Armstrong R-OK · Senate | 2026-03-27 | sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 2, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all MRSH political trades →Which hedge funds own MRSH?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Marshall Wace | 1.04M | $173.90M | +72% |
| D.E. Shaw David Shaw | 840K | $139.94M | -51% |
| Citadel Ken Griffin | 231K | $38.47M | +69% |
| Millennium Management Israel Englander | 71K | $11.91M | -11% |
| Bridgewater Associates Ray Dalio | 18K | $2.99M | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are MARSH & MCLENNAN COMPANIES, INC. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 23, 26 | Mills Stacy | Vice President and Controller | SELL | 1.2K | $243K |
| Oct 23, 26 | Klisura Dean Michael | President & CEO, Marsh RE | SELL | 4.2K | $839K |
| Sep 2, 26 | Doyle John Q | President and CEO | SELL | 16.7K | $3.1M |
| Sep 2, 26 | Brennan Katherine | SVP and General Counsel | SELL | 1.2K | $225K |
| Aug 6, 26 | Jones John Jude | Chief Marketing Officer | SELL | 6.5K | $1.2M |
| Jul 29, 26 | Beswick Paul | SVP, Chief Information Officer | SELL | 713 | $141K |
| Jul 28, 26 | South Martin | Chief Client Officer | SELL | 7.1K | $1.3M |
| Jul 23, 26 | Yates Lloyd M | Director | SELL | 12.0K | $2.1M |
| Mar 11, 26 | Jones John Jude | Chief Marketing Officer | SELL | 2.4K | $410K |
| Mar 4, 26 | Doyle John Q | President and CEO | SELL | 16.7K | $3.1M |
SEC Form 4 filings as of Nov 3, 2026
See cluster-buy signals across all tickers →What are MRSH's key statistics?
Key statistics as of Nov 3, 2026
How does MRSH's valuation compare with the Financials sector?
| Metric | MRSH | Financials median | Companies in median |
|---|---|---|---|
| P/E ratio | 23.9 | 12.9 | 212 |
| Net margin | 14.20% | 20.22% | 197 |
| Return on equity | 27.15% | 12.39% | 221 |
Medians over the Financials stocks whose key statistics were refreshed in the last 35 days (newest Nov 4, 2026). P/E excludes loss-making companies.
MRSH price chart
Powered by TradingViewWhat does MARSH & MCLENNAN COMPANIES, INC. do?
Marsh & McLennan Companies, Inc. is a global professional services firm specializing in advisory services and insurance solutions focused on risk, strategy, and people. It operates primarily through two key segments: Risk and Insurance Services, which provides risk management, insurance and reinsurance broking, strategic advisory, analytics, and program management; and Consulting, encompassing health, wealth, career, and investment services. Renowned subsidiaries include Marsh, the world's leading insurance broker with a significant market share, Mercer for talent and retirement solutions, and Oliver Wyman for management consulting. The company serves clients across diverse industries worldwide, addressing challenges like cybersecurity threats, AI adoption, workforce redesign, and salary trends in various regions. With a market capitalization approaching $90 billion, robust revenue growth—reaching $24.46 billion in 2024—and consistent dividend payments, Marsh & McLennan Companies, Inc. plays a pivotal role in the financial services landscape by delivering data-driven insights, technology innovations, and risk mitigation strategies to businesses navigating complex global environments.